Medeze Group PCL (BKK:MEDEZE) EBIT : ฿ Mil (TTM As of Mar. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Medeze Group PCL EBIT?

Medeze Group PCL's earnings before interest and taxes (EBIT) for the six months ended in Mar. 2024 was ฿75.2 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Medeze Group PCL's annualized ROC % for the quarter that ended in Mar. 2024 was 6.73%. Medeze Group PCL's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 30.91%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield.

Medeze Group PCL EBIT Historical Data

The historical data trend for Medeze Group PCL's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medeze Group PCL EBIT Chart

Medeze Group PCL Annual Data

Trend

EBIT

Medeze Group PCL Semi-Annual Data
	Mar23	Mar24
EBIT	85.49	75.23

Competitive Comparison of Medeze Group PCL's EBIT

For the Medical Care Facilities subindustry, Medeze Group PCL's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medeze Group PCL's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Medeze Group PCL's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Medeze Group PCL's EV-to-EBIT falls into.

Medeze Group PCL EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ฿ Mil.

Medeze Group PCL (BKK:MEDEZE) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Medeze Group PCL's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

	ROC % (Q: Mar. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Mar. 2023 )	+	Invested Capital (Q: Mar. 2024 ))	/ count )
=	70.318 * ( 1 - 16.93% )	/	( (0	+	867.641)	/ 1 )
=	58.4131626	/	867.641
=	6.73 %

where

	Invested Capital		(Q: Mar. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	0	-	0	-	( 0	-	max(0, 0	-	0	+	0	))
=	0

	Invested Capital		(Q: Mar. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	1118.027	-	109.981	-	( 226.578	-	max(0, 161.048	-	301.453	+	226.578	))
=	867.641

Note: The Operating Income data used here is one times the annual (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Medeze Group PCL's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Mar. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Mar. 2023		Q: Mar. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	75.233	/	( ( (0 + max(0, 0))	+	(243.43 + max(-86.372, 0)) )	/	1 )
=	75.233	/	( ( 0	+	243.43 )	/	1 )
=	75.233	/	243.43
=	30.91 %

where Working Capital is:

	Working Capital		(Q: Mar. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0	+	0	+	0)	-	(0	+	0	+	0)
=	0

	Working Capital		(Q: Mar. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(34.598	+	16.453	+	18.599)	-	(109.981	+	43.086	+	2.955)
=	-86.372

When net working capital is negative, 0 is used.

Note: The EBIT data used here is one times the annual (Mar. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Medeze Group PCL's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Mar. 2024 )
	=		/	8437.996
	=	%

Medeze Group PCL EBIT Related Terms

Thank you for viewing the detailed overview of Medeze Group PCL's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Medeze Group PCL Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Medeze Group PCL (BKK:MEDEZE) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

Phutthamonthon Sai 4 Road, 28/9 Moo 8, Krathum Lom, Sam Phran, Nakhon Pathom, THA, 73220

Website

https://www.medezegroup.com

Medeze Group PCL is engaged in the business of providing stem cell storage, analyzing, isolation, cultivation, and preservation services for medical use. It is organised into four reportable segments: Stem cell sample collection service segment; White blood cell potential testing service segment; Other services segment and Sales of products segment.

Medeze Group PCL Headlines

No Headlines